Sintx Technologies (SINT) Gross Profit Growth (3y) (2016 - 2026)
Sintx Technologies (SINT) Gross Profit Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | 3.15% |
| 10 | Sintx Technologies | 6.22 Mn | 4.33 Mn | 144,000.00 | -30.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.07% |
| Dec 31, 2025 | -36.52% |
| Sep 30, 2025 | -34.89% |
| Jun 30, 2025 | -31.06% |
| Mar 31, 2025 | 35.91% |
| Dec 31, 2024 | 113.27% |
| Sep 30, 2024 | 129.07% |
| Jun 30, 2024 | 183.06% |
| Mar 31, 2024 | 126.37% |
| Dec 31, 2023 | 170.85% |
| Sep 30, 2023 | 250.76% |
| Jun 30, 2023 | 114.39% |
| Mar 31, 2023 | 117.35% |
| Dec 31, 2022 | 124.45% |
| Sep 30, 2022 | 148.35% |
| Jun 30, 2022 | 72.33% |
| Mar 31, 2022 | 39.63% |
| Dec 31, 2021 | 26.17% |
| Sep 30, 2021 | -67.41% |
| Jun 30, 2021 | -73.58% |